The IBS gut-brain connection describes a disorder of gut-brain interaction. The tissue itself looks normal on a scope or scan, but the communication between your gut and your brain is disrupted. IBS involves dysfunction in the enteric nervous system, the network of nerves that controls muscle contractions, fluid balance, and blood flow throughout the digestive tract, and in how the brain processes signals coming from the gut.

When that two-way communication becomes dysregulated, you get the hallmark symptoms: abdominal pain or cramping, bloating, gas, and changes in bowel movements. Some people experience mostly diarrhea, others mostly constipation, and many alternate between the two.

How This Is Different From Other Digestive Issues

This is the part most people never get explained clearly.

• IBD (Crohn’s, ulcerative colitis) involves actual inflammation and visible tissue damage. IBS does not. The gut lining looks structurally normal, even though it isn’t functioning normally.
• Food intolerances can coexist with IBS and make symptoms worse, but IBS itself isn’t explained by a single dietary trigger. The underlying issue is nervous system reactivity, and food is often a trigger rather than the root cause.
• A “sensitive stomach” or occasional stress-related upset comes and goes. IBS is a persistent pattern rooted in genuine nerve hypersensitivity. The gut sends pain and discomfort signals that are amplified beyond what the actual stimulus warrants.

That last point is key. Brain imaging studies have shown measurably altered activity in regions that process gut sensations, including the insula, anterior cingulate cortex, and prefrontal cortex, in IBS patients compared to healthy controls. This isn’t “in your head” in the dismissive sense. It’s a measurable, physical expression of the IBS gut-brain connection, part of what researchers now call the microbiota-gut-brain axis, and it shows up on a scan.

What Drives It

IBS doesn’t have one single cause. The research points to a few overlapping contributors.

• Stress: both mental and physical stress can push the gut-brain axis into an over-reactive state. Elevated cortisol and disrupted serotonin signaling, most of which is produced in the gut rather than the brain, are consistently found in IBS patients.
• Bacterial imbalance (SIBO): small intestinal bacterial overgrowth is significantly more common in IBS patients than in healthy controls. Meta-analyses estimate it’s present in roughly a third of IBS patients, compared to much lower rates in the general population. When bacteria overpopulate the small intestine, they interfere with the coordinated muscle contractions that move food through the digestive tract and produce excess gas that contributes to bloating and pain.
• Leaky gut and food sensitivity: increased intestinal permeability has been documented in a significant proportion of IBS patients, particularly those with diarrhea-predominant symptoms. When the gut lining becomes more permeable, it allows more bacterial fragments and food antigens through, triggering low-grade immune activation that heightens gut sensitivity. Whether this is a cause or a consequence of IBS is still debated, but it’s a measurable finding.
• Post-infectious IBS: some cases develop after a bout of food poisoning or gastroenteritis. About 1 in 10 people who get a significant GI infection go on to develop IBS afterward. Their gut bacteria patterns look strikingly similar to those seen in diarrhea-predominant IBS, suggesting a shared underlying mechanism.

The Liver Connection

This surprises people, but it shouldn’t. Traditional Chinese Medicine has treated digestive disorders as a liver-first problem for centuries. The most common TCM diagnosis for IBS with diarrhea is “liver depression and spleen deficiency,” the idea that a stressed or stagnant liver disrupts digestive function downstream. Modern gastroenterology is catching up to this concept through what’s called the gut-liver axis. The liver receives about 70% of its blood supply directly from the intestines, making it the first organ to encounter everything that crosses the gut lining.

Recent research has found that IBS patients have measurably higher levels of bacterial DNA in their blood, evidence that microbial material is leaking through the gut wall and reaching the liver through the portal vein. This bacterial translocation correlates with markers of liver stress, even when standard liver enzymes remain in the normal range. The gut and liver stay in constant biochemical conversation through bile acids, and when that conversation breaks down, both systems suffer.

The Bottom Line

At the center of all of it is the IBS gut-brain connection. It has multiple potential drivers, including stress load, liver-gut axis dysfunction, bacterial balance, and gut lining integrity. Effective care usually means identifying which of these is driving your specific pattern rather than treating IBS as one-size-fits-all.

If you’ve been managing IBS symptoms without a clear explanation of why they’re happening, that’s usually the missing piece.

Where This Leaves You

In the twenty-five years I’ve spent supporting patients nutritionally, digestive issues like IBS have been a consistent source of frustration, and most of it traces back to labeling and diagnosis rather than function. Patients get a diagnosis and a templated diet, and that approach has always felt limiting. What’s changed is that we now have both the science behind this integrated view of the gut, liver, and nervous system, and the objective data to focus on function instead of getting stuck narrowing down a label.

Given everything above, a few things become obvious.

If IBS involves multiple interconnected systems, including the gut, liver, microbiome, and nervous system, then understanding where your symptoms are coming from starts with seeing the full picture. This is why we begin with a complete systems review: mapping your lifestyle, history, and symptom patterns to identify which of these areas deserves attention first. From there, we can prioritize the right testing rather than guessing at a starting point.

Since food sensitivity is one of the clearest, most testable contributors discussed above, food sensitivity testing is a practical starting point. It helps narrow down what may be feeding the reactivity, giving you a more structured path forward than guessing through elimination diets alone.

Because bacterial imbalance, both overgrowth and insufficient beneficial flora, plays such a direct role in gut function, a microbiome assessment helps identify patterns of imbalance: what’s overpopulated, what’s underrepresented, and how that balance is likely affecting motility and inflammation. That information makes targeted support, like specific probiotic strains or dietary adjustments, far more precise.

And because the enteric nervous system doesn’t operate in isolation from the rest of the nervous system, hypersensitivity in the gut can both stem from and contribute to nervous system irritation elsewhere, including the musculoskeletal system. This is the same principle behind chiropractic care: supporting proper nervous system function as part of a whole-body approach. The connection between nervous system regulation and gut function is well established, and for patients whose IBS is intertwined with broader nervous system stress, addressing that component can be a meaningful part of the overall picture rather than a separate, unrelated treatment.

None of these steps replace the others. Each one looks at a different part of the same interconnected system.

---

Nutrition, gut health, and how your body functions are deeply connected.

At Well Rooted Health, nutritional support is part of a whole-person approach rooted in how your spine and nervous system are functioning. Every new patient relationship begins with a comprehensive physical exam, in Westfield NJ, New York City, or virtually.

Request an Appointment: https://wellrootedhealth.clientsecure.me
Call NJ: 908-588-7532 · NY: 212-655-5802
Email: info@gowellrooted.com

References

1. Aizawa E, Sato Y, Kochiyama T, et al. Altered cognitive function of prefrontal cortex during error feedback in patients with irritable bowel syndrome, based on fMRI and dynamic causal modeling. Gastroenterology. 2012;143:1188–98.
2. Hall GB, Kamath MV, Collins S, et al. Heightened central affective response to visceral sensations of pain and discomfort in IBS. Neurogastroenterol Motil. 2010;22:276–80.
3. Lee SH, et al. Irritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and Metabolic Syndrome. Yonsei Med J. 2015;57(1):146-52.
4. Nasser Y, Shin A, Ford AC, Camilleri M, Black CJ. Pathophysiology of Irritable Bowel Syndrome. Lancet Gastroenterol Hepatol. 2026.
5. Barbaro MR, Cremon C, Marasco G, et al. Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome. Gastroenterology. 2024.
6. Shah A, Talley NJ, Jones M, et al. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. Am J Gastroenterol. 2020.
7. Sung JJ, Leung WK, Ching JY, et al. Agreements among traditional Chinese medicine practitioners in the diagnosis and treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2004.
8. Gu Y, Li L, Yang M, et al. Bile Acid-Gut Microbiota Crosstalk in Irritable Bowel Syndrome. Crit Rev Microbiol. 2023.
9. Cryan JF, O’Riordan KJ, Cowan CSM, et al. The Microbiota-Gut-Brain Axis. Physiol Rev. 2019.
10. Wu S, Yuan C, Yang Z, et al. Non-Alcoholic Fatty Liver Is Associated With Increased Risk of Irritable Bowel Syndrome: A Prospective Cohort Study. BMC Med. 2022.
11. Albillos A, de Gottardi A, Rescigno M. The Gut-Liver Axis in Liver Disease: Pathophysiological Basis for Therapy. J Hepatol. 2020.
12. Liu R, Luo Y, Ma J, et al. Traditional Chinese Medicine for Functional Gastrointestinal Disorders and Inflammatory Bowel Disease: Narrative Review of the Evidence and Potential Mechanisms Involving the Brain-Gut Axis. Front Pharmacol. 2024.
13. Miyauchi E, Shimokawa C, Steimle A, Desai MS, Ohno H. The Impact of the Gut Microbiome on Extra-Intestinal Autoimmune Diseases. Nat Rev Immunol. 2023.
14. Zhan K, Zheng H, Li J, et al. Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome. Biomed Res Int. 2020.
15. Chen Y, Feng S, Li Y, et al. Gut microbiota and intestinal immunity, a crosstalk in irritable bowel syndrome. Immunology. 2024.

Source protocol: Wei Laboratories, Inc., Irritable Bowel Syndrome (IBS) Protocol.